Prevention and Reduction of Falls: Testing and Evaluating Cutting Edge Haptic Technology
NCT: NCT07781397 · ENROLLING_BY_INVITATION
Brief Summary
This study evaluates whether a drug-free, non-invasive haptic patch (LIBERTY Patch) affects fall-risk classification and balance/mobility confidence in adults ages 55 to 85. Approximately 150 participants are assigned to wear either the active LIBERTY Patch or a visually identical sham patch daily for 7 days. Balance and mobility are assessed using the FallSkip wearable device and a Falls Efficacy Scale questionnaire at baseline and again after 7 days. Neither participants nor investigators know which patch is assigned during the study period, though this can be unblinded in an emergency.
Frequently Asked Questions
What is Prevention and Reduction of Falls: Testing and Evaluating Cutting Edge Haptic Technology?
Prevention and Reduction of Falls: Testing and Evaluating Cutting Edge Haptic Technology is a clinical trial registered under NCT07781397. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT07781397?
The current status of NCT07781397 (Prevention and Reduction of Falls: Testing and Evaluating Cutting Edge Haptic Technology) is: ENROLLING_BY_INVITATION.
When did Prevention and Reduction of Falls: Testing and Evaluating Cutting Edge Haptic Technology start?
Prevention and Reduction of Falls: Testing and Evaluating Cutting Edge Haptic Technology started on 2025-06-16.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.